Literature DB >> 23713431

Stromal cell-derived factor-1 receptor CXCR4-overexpressing bone marrow mesenchymal stem cells accelerate wound healing by migrating into skin injury areas.

Dazhi Yang1, Shijin Sun, Zhengguo Wang, Peifang Zhu, Zailiang Yang, Bo Zhang.   

Abstract

Stromal cell-derived factor-1 (SDF-1) and its membrane receptor C-X-C chemokine receptor type 4 (CXCR4) are involved in the homing and migration of multiple stem cell types, neovascularization, and cell proliferation. This study investigated the hypothesis that bone marrow-derived mesenchymal stem cells (BMSCs) accelerate skin wound healing in the mouse model by overexpression of CXCR4 in BMSCs. We compared SDF-1 expression and skin wound healing times of BALB/c mice, severe combined immunodeficiency (SCID) mice, and immune system-deficient nude mice after (60)Co radiation-induced injury of their bone marrow. The occurrence of transplanted adenovirus-transfected CXCR4-overexpressing male BMSCs in the wound area was compared with the occurrence of untransfected male BALB/c BMSCs in (60)Co-irradiated female mice skin wound healing areas by Y chromosome marker analyses. The wound healing time of BALB/c mice was 14.00±1.41 days, whereas for the nude and SCID mice it was 17.16±1.17 days and 19.83±0.76 days, respectively. Male BMSCs could be detected in the surrounding areas of (60)Co-irradiated female BALB/c mice wounds, and CXCR4-overexpressing BMSCs accelerated the wound healing time. CXCR4-overexpressing BMSCs migrate in an enhanced manner to skin wounds in a SDF-1-expression-dependent manner, thereby reducing the skin wound healing time.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23713431      PMCID: PMC3666362          DOI: 10.1089/cell.2012.0046

Source DB:  PubMed          Journal:  Cell Reprogram        ISSN: 2152-4971            Impact factor:   1.987


  29 in total

Review 1.  Clinical approach to wounds: débridement and wound bed preparation including the use of dressings and wound-healing adjuvants.

Authors:  Christopher E Attinger; Jeffrey E Janis; John Steinberg; Jaime Schwartz; Ali Al-Attar; Kara Couch
Journal:  Plast Reconstr Surg       Date:  2006-06       Impact factor: 4.730

Review 2.  Regenerative capacity and the developing immune system.

Authors:  Anthony L Mescher; Anton W Neff
Journal:  Adv Biochem Eng Biotechnol       Date:  2005       Impact factor: 2.635

3.  The migration of bone marrow-derived non-hematopoietic tissue-committed stem cells is regulated in an SDF-1-, HGF-, and LIF-dependent manner.

Authors:  Magda Kucia; Wojtek Wojakowski; Ryan Reca; Bogdan Machalinski; Jolanta Gozdzik; Marcin Majka; Jarek Baran; Janina Ratajczak; Mariusz Z Ratajczak
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2006-03-28       Impact factor: 4.291

4.  Effect of cytokines and growth factors on the macrophage colony-stimulating factor secretion by human bone marrow stromal cells.

Authors:  A Besse; F Trimoreau; V Praloran; Y Denizot
Journal:  Cytokine       Date:  2000-05       Impact factor: 3.861

5.  Wound repair by bone marrow stromal cells through growth factor production.

Authors:  Yongbo Liu; Deborah S Dulchavsky; Xiaohua Gao; David Kwon; Michael Chopp; Scott Dulchavsky; Subhash C Gautam
Journal:  J Surg Res       Date:  2006-10-11       Impact factor: 2.192

6.  Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors.

Authors:  Marek Honczarenko; Yi Le; Marcin Swierkowski; Ionita Ghiran; Aleksandra M Glodek; Leslie E Silberstein
Journal:  Stem Cells       Date:  2005-10-27       Impact factor: 6.277

7.  Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury.

Authors:  Florian Tögel; Jorge Isaac; Zhuma Hu; Kathy Weiss; Christof Westenfelder
Journal:  Kidney Int       Date:  2005-05       Impact factor: 10.612

8.  Mobilizing of haematopoietic stem cells to ischemic myocardium by plasmid mediated stromal-cell-derived factor-1alpha (SDF-1alpha) treatment.

Authors:  Yao Liang Tang; Keping Qian; Y Clare Zhang; Leping Shen; M Ian Phillips
Journal:  Regul Pept       Date:  2005-02-15

9.  CXCR4-transgene expression significantly improves marrow engraftment of cultured hematopoietic stem cells.

Authors:  Sebastian Brenner; Narda Whiting-Theobald; Toshinao Kawai; Gilda F Linton; Andrew G Rudikoff; Uimook Choi; Martin F Ryser; Philip M Murphy; Joan M G Sechler; Harry L Malech
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

10.  A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow.

Authors:  Robert F Wynn; Claire A Hart; Carla Corradi-Perini; Liam O'Neill; Caroline A Evans; J Ed Wraith; Leslie J Fairbairn; Ilaria Bellantuono
Journal:  Blood       Date:  2004-07-13       Impact factor: 22.113

View more
  23 in total

Review 1.  The Role of Chemokines in Mesenchymal Stem Cell Homing to Wounds.

Authors:  Anne M Hocking
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

2.  Intravenous administration of atorvastatin-pretreated mesenchymal stem cells improves cardiac performance after acute myocardial infarction: role of CXCR4.

Authors:  Na Li; Yue-Jin Yang; Hai-Yan Qian; Qing Li; Qian Zhang; Xiang-Dong Li; Qiu-Ting Dong; Hui Xu; Lei Song; Hao Zhang
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

Review 3.  Engineered Mesenchymal Stem Cells for Targeting Solid Tumors: Therapeutic Potential beyond Regenerative Therapy.

Authors:  Shen Cheng; Susheel Kumar Nethi; Sneha Rathi; Buddhadev Layek; Swayam Prabha
Journal:  J Pharmacol Exp Ther       Date:  2019-06-07       Impact factor: 4.030

4.  Combined therapy with atorvastatin and atorvastatin-pretreated mesenchymal stem cells enhances cardiac performance after acute myocardial infarction by activating SDF-1/CXCR4 axis.

Authors:  Xia-Qiu Tian; Yue-Jin Yang; Qing Li; Jun Xu; Pei-Sen Huang; Yu-Yan Xiong; Xiang-Dong Li; Chen Jin; Kang Qi; Lei-Pei Jiang; Gui-Hao Chen; Li Qian; Jiandong Liu; Yong-Jian Geng
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

5.  Mesenchymal stem cell-laden, personalized 3D scaffolds with controlled structure and fiber alignment promote diabetic wound healing.

Authors:  Shixuan Chen; Hongjun Wang; Yajuan Su; Johnson V John; Alec McCarthy; Shannon L Wong; Jingwei Xie
Journal:  Acta Biomater       Date:  2020-04-05       Impact factor: 8.947

6.  Exogenous IL-4-expressing bone marrow mesenchymal stem cells for the treatment of autoimmune sensorineural hearing loss in a guinea pig model.

Authors:  Chang-qiang Tan; Xia Gao; Lang Guo; He Huang
Journal:  Biomed Res Int       Date:  2014-04-22       Impact factor: 3.411

Review 7.  Intravenously Infused Stem Cells for Cancer Treatment.

Authors:  Alison R Mercer-Smith; Ingrid A Findlay; Hunter N Bomba; Shawn D Hingtgen
Journal:  Stem Cell Rev Rep       Date:  2021-06-17       Impact factor: 5.739

8.  Evaluation of Acellular Dermal Matrix (ADM) as a Scaffold for Adipose-Derived Stem Cell Transfer in the Rat Model.

Authors:  Maryam Jahanian; Sara Hoseini; Amir Atashi; Mohsen Saberi; Seyyed Aboozar Hoseini; Kambiz Mozaffari; Mohammad Javad Fatemi
Journal:  World J Plast Surg       Date:  2021-05

Review 9.  The Use of Stem Cells in Burn Wound Healing: A Review.

Authors:  Fadi Ghieh; Rosalyn Jurjus; Amir Ibrahim; Alice Gerges Geagea; Hisham Daouk; Bassel El Baba; Sana Chams; Michel Matar; Wadih Zein; Abdo Jurjus
Journal:  Biomed Res Int       Date:  2015-07-07       Impact factor: 3.411

10.  Function of chemokine (CXC motif) ligand 12 in periodontal ligament fibroblasts.

Authors:  Yuichi Yashiro; Yoshiaki Nomura; Mikimoto Kanazashi; Koji Noda; Nobuhiro Hanada; Yoshiki Nakamura
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.